William E. Smith, Pharm.D., MPh, Ph.D.
   
Home Button Professional Issues Lecture Topics Consulting Publications Advisory Panel About
Publications
  1. Smith WE. The future role of the hospital pharmacist in the patient care area. Am J Hosp Pharm. 1967; 24:228-231.
  2. Smith WE. Role of a pharmacist in improving rational drug therapy as part of the patient care team. Drug Intell. 1967; 8:244-249.
  3. Smith WE. Drugs, the patient, the hospital. Drug Intell Clin Pharm. 1969; 3:244-247.
  4. Smith WE. Clinical pharmacy. Drug Intell Clin Pharm. 1969; 3:322-323.
  5. Smith WE, Mackewicz DW. An economic analysis of the PACE pharmacy service. Am J Hosp Pharm. 1970; 27:123-126.
  6. Smith WE. Using the patient drug profile. Drug Intell Clin Pharm. 1970; 4:73-76.
  7. Smith WE. Clinical pharmacy services - management by objectives. Am J Hosp Pharm. 1971; 28:692-696.
  8. Briggs GG, Smith WE. Pharmacist-physician drug consultations in a community hospital. Am J Hosp Pharm. 1974; 31:247-253.
  9. Smith WE, Brodie DC. How to begin a clinical pharmacy programme. Aust J Hosp Pharm. 1977; 7:61-65.
  10. Brodie DC, Smith WE, Hlynka JN. Model for drug usage review in a hospital. Am J Hosp Pharm. 1977; 34:251-254.
  11. Smith WE, Weiblen JW. Charging for hospital pharmaceutical services: product cost, per diem fees and fees for special clinical services. Am J Hosp Pharm. 1979; 36:355-359.
  12. Smith WE, Brodie DC. The pharmacy service of Memorial Hospital Medical Center. Drug Intell Clin Pharm. 1980; 14:599-604.
  13. Hlynka JN, Smith WE, Brodie DC. Developing drug-use profiles from drug-charge records. Am J Hosp Pharm. 1979; 36:1347-1351.
  14. Smith WE. A conceptual model for evaluating a pharmacist's clinical practice in the hospital setting. Drug Intell Clin Pharm. 1982; 16:400-403.
  15. Schweigert BF, Oppenheimer PR, Smith WE. Hospital pharmacists as a source of drug information for physicians and nurses. Am J Hosp Pharm. 1982; 39:74-77.
  16. Fink A, Kosecoff J, Oppenheimer PR, Smith WE, Brodie DC. Assessing whether a clinical pharmacy program is meeting its goals. Am J Hosp Pharm. 1982;39:806-810.
  17. Smith WE. Clinical pharmacy in the 1980's, Harvey A.K. Whitney Lecture. Am J Hosp Pharm. 1983; 40:223-9.
  18. McGhan WF, Smith WE, Adams DW. A randomized trial comparing pharmacists and technicians as dispensers of prescriptions for ambulatory patients. Med Care. 1983; 4:445-453.
  19. Barker KN, Pearson RE, Hepler CD, Smith WE, Papas CA. Effect of an automated bedside dispensing machine on medication errors. Am J Hosp Pharm. 1984; 41:1352-1358.
  20. Brodie DC, Smith WE. Implications of new technology for pharmacy education and practice. Am J Hosp Pharm. 1985; 42:81-95.
  21. Smith WE, Schweigert BF. JCAH survey experience: Memorial Medical Center. Am J Hosp Pharm. 1986; 43:2420-2.
  22. Smith WE. Ethical, economic, and professional issues in home health care. Am J Hosp Pharm. 1986; 43:695-698.
  23. Smith WE. Excellence in the management of clinical pharmacy services. Am J Hosp Pharm. 1988; 45:319-325.
  24. Ambrose PA, Smith WE, Palarea ER. A decade of experience with a clinical pharmacokinetics service. Am J Hosp Pharm. 1988; 45:1879-1886.
  25. Smith WE. Our mission and our message: safe use of drugs. Am J Hosp Pharm. 1990; 47:323-325.
  26. Smith WE, Benderev K. Levels of pharmaceutical care: a theoretical model. Am J Hosp Pharm. 1991; 48:540-546.
  27. Smith WE. Pharmacist clinical practice. Pharm Prt Mgt Qtrly. 1997; 87:30-39.
  28. Smith WE. Pharmacy alternative futures. Pharm Prt Mgt Qtrly. 1998; 18:2: 37-47.
  29. Smith WE. A pharmacy plan for the hospital. Pharm Prt Mgt Qtrly. 1999; 18.4: 29-42.
  30. Smith WE, Ray M, & Shannon, D. Physician’s current and future expectations of pharmacists. Am J Health-Syst Pharm. 2002; 59: 50-57.
  31. Smith WE. Clinical pharmacy – reflections and forecasts. Ann of Pharmacotherapy. 2007; 41:xxxx.xx, www.theannals.com

Other Publications

  1. Smith WE, O'Malley CD, Weiblen JW. Clinical pharmacy: general hospital. Hospitals. 1970; 44:88-94.
  2. Smith WE. Clinical pharmacy, community pharmacy, future. Calif Pharm. 1973; Jan:18-22.
  3. Brodie DC, Smith WE. Constructing a conceptual model of drug utilization review. Hospitals. 1976; 50:143-145,148-9.
  4. Smith WE. Drug cost containment in the hospital. Hosp Form. 1978; Sept:695-698.
  5. Smith WE. Marketing pharmacy services. Pharm Mgt. 1991; 6:41.43.

Book Chapters

  1. Chapter 30: Hospital pharmacy. The Dispensing of Medication, 1971.
  2. Developing a clinical pharmacy program in the hospital. Chapter 5. Perspectives in Clinical Pharmacy, 1972.
  3. Centralized and decentralized clinical pharmacy services. Clinical Pharmacy. Elsevier/North Holland Biomedical Press, 1977.
  4. Decentralized clinical pharmacy services. Chapter VI.9. Handbook of Institutional Pharmacy Practice. Williams and Wilkins, 1979, p.465.
  5. Justification of programs. Chapter 23. The Practice of Pharmacy. Harvey Whitney Books. 1981.
  6. Pharmacy services in the community hospital medical center. Chapter 36. The Practice of Pharmacy. Harvey Whitney Books. 1981.
  7. Decentralized pharmacy services. Chapter 54. Handbook of Institutional Pharmacy Practice.
    Williams and Wilkins, 2nd Ed., 1985.
  8. Decentralized pharmacy services. Chapter 38. Handbook of Institutional Pharmacy Practice. 3rd Ed. American Society of Hospital Pharmacists. 1992.
  9. Smith WE. Clinical pharmacy careers in health systems. Enclycopedia of Clinical Pharmacy.
    Marcel Dekker. 2002.

Documents

Monograph:
" Clinical Pharmacy Services in a Community Hospital." Pharmacy Related Branch, National Center for Health Services Research and Development, Department of Health, Education, and Welfare, DHEW Pub. No. HSM-72-3019.

Monograph:
" The Economic Feasibility of Clinical Pharmacy in the Hospital Setting: Personnel Costs." Pharmacy Related Branch, National Center for Health Services Research and Development HSMA, DHEW, Contract HSM-110-71-208, Document PB-220-616, U.S. Department of Commerce, National Technical Information Service

Dissertation

Smith WE Jr. Enriching the job of the chain store pharmacist: analysis of potential and synthesis of a practice model. Dissertation Abstracts International, 55, 3835B. 1995. (University Microfilms No. DA9503409).

Significant Contributions to Publications and Reports

  1. Pharmacists for the Future. The Report of the Study Commission on Pharmacy. 1977.
  2. Study of hospital inpatients for pharmacist clinical services. 1984. Project funded by the American Society of Hospital Pharmacists Foundation.
  3. Folli HF et al. Medication error prevention by clinical pharmacists in two children’s hospitals.Pediatrics. 1987;79: 718-722.
  4. Williard RL, Tresolini CP, & O’Neil EH. Characteristics, importance, and implications of comprehensive drug therapy management. AmJ Health-Syst Pharm. 1996;53: 623-632.
  5. AACP White Paper. A vision of pharmacy’s future roles, respsonsibilities, and manpower needs in the United States. Pharmacotheapy. 2000; 20: 991-1020.
  6. Knapp KK & Ray MD. A pharmacy response to the institute of medicine’s 2001 initiative on quality of care. Am J Health-Syst Pharm. 2002; 59: 2443-2450.
  7. Pharmacy practice research roundtable. Advancing pharmacy practice through research: a 2003 perspective. Am J Pharm. 2004.

Special Recognitions

Recognized as one of three pharmacists from the United States who made the greatest contribution to clinical pharmacy in Japan. Horioka M. Principles and practice of dispensing pharmacy. Nanzando Co. Ltd, Tokyo.

Appointment to the National Advisory Council, Agency for Health care Research and Quality, Department of Health and Human Services (2008-2010) (first pharmacist appointed)

 

 

 

 

 

 

 

 

 

 


William E. Smith, PharmD, MPH, PhD
School of Pharmacy, Virginia Commonwealth University
Professor of Pharmacy (retired)

804-828-3009
Cell: 804-370-9574
FAX: 804-828-0343
Email: wesmith1@vcu.edu

Smith Building, Suite 660
410 North 12th Street
P.O. Box 980533
Richmond, VA 23298-0533

Richmond, VA 23298-0002